A blueprint for a sustainable future

The Sustainable Development Goals (SDGs) are the blueprint for a more sustainable future. Ahead of 2030, these ambitious goals drive momentum in the global health community toward a shared agenda of peace and prosperity for all.

To achieve the goals, partnering across sectors is fundamental

The innovative pharmaceutical industry is addressing the world’s most pressing challenges through our partnerships, bringing a diversity of skills and expertise to help people live long, healthier, more productive lives.

Our approach

We are strengthening health systems to meet patients’ needs, developing and producing medicines and vaccines and increasing the availability, accessibility, and affordability of health services.

Our collaborations

With over 300 active and completed collaborations, this site details the scope, scale, and breadth of our work to to strengthen health systems and expand access to quality healthcare.

Our members and partners

IFPMA members are part of a dedicated, thriving community consisting of over 90 of the global pharmaceutical industry’s most innovative companies and member associations.

The innovative pharmaceutical industry is committed to delivering health for all

Delivering better health for millions of people is about much more than medicine and vaccine innovation – it requires establishing strong health systems, developing public health education, and strengthening standards and regulations.

We believe there are three key components for the global health community to commit to:
Upholding quality primary healthcare
Investing more, investing better in health
Improving access to medicines and vaccines
Picture of a mother and child

Achieving Universal Health Coverage (UHC)

SDG 3.8, universal health coverage (UHC) – ensuring that all individuals receive the health services they need without suffering financial hardship – is at the heart of the health-related SDGs and the foundation for improving health and well-being globally. Achieving UHC is one of the most important health challenges of our time and a core focus for us.


Reporting on progress, calling for continued collaborative action

Access our wider research and share infographics and resources on the subject of global health progress.

Explore the full depth and diversity of our collaborative work

Global Health Progress is an one-of-a-kind resource hub highlighting collaborations between the innovative pharmaceutical industry and our global stakeholders to support the SDGs.

SDGs in Focus

Read the story of how the innovative pharmaceutical industry and our partners are bringing a diversity of skills and expertise to help people live longer, healthier, more productive lives.


Explore our collaborations

Search our database to discover our cross-sector collaborations that target specific geographies, populations and disease areas to contribute to the Sustainable Development Goals.


About this site

Global Health Progress is hosted by the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA). IFPMA represents over 90 innovative pharmaceutical companies and associations around the world. Our industry’s almost three million employees discover, develop, and deliver medicines and vaccines that advance global health.

Based in Geneva, IFPMA has official relations with the United Nations and contributes industry to help the global health community improve the lives of people everywhere.